Annual report pursuant to Section 13 and 15(d)

Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)

v3.24.1
Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 1,799,357 $ 3,694,069
Gross Unrealized Gains
Gross Unrealized Losses (48,841)
Fair Value 1,799,357 3,645,228
Cash Equivalents 1,799,357 978,462
Short-Term Investments 2,666,766
Long-Term Investments
Cash and Cash Equivalents [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   978,462
Gross Unrealized Gains  
Gross Unrealized Losses  
Fair Value   978,462
Cash Equivalents   978,462
Short-Term Investments  
Long-Term Investments  
Money Market Funds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 1,799,357 978,462
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value 1,799,357 978,462
Cash Equivalents 1,799,357 978,462
Short-Term Investments
Long-Term Investments
Investments [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   2,715,607
Gross Unrealized Gains  
Gross Unrealized Losses   (48,841)
Fair Value   2,666,766
Cash Equivalents  
Short-Term Investments   2,666,766
Long-Term Investments  
Corporate Notes/Bonds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost   2,715,607
Gross Unrealized Gains  
Gross Unrealized Losses   (48,841)
Fair Value   2,666,766
Cash Equivalents  
Short-Term Investments   2,666,766
Long-Term Investments